HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peptosome Coadministration Improves Nanoparticle Delivery to Tumors through NRP1-Mediated Co-Endocytosis.

Abstract
Improving the efficacy of nanoparticles (NPs) delivery to tumors is critical for cancer diagnosis and therapy. In our previous work, amphiphilic peptide APPA self-assembled nanocarriers were designed and constructed for cargo delivery to tumors with high efficiency. In this study, we explore the use of APPA self-assembled peptosomes as a nanoparticle adjuvant to enhance the delivery of nanoparticles and antibodies to integrin αvβ3 and neuropilin-1 (NRP1) positive tumors. The enhanced tumor delivery of coadministered NPs was confirmed by better magnetosome (Mag)-based T2-weighted magnetic resonance imaging (MRI), liposome-based fluorescence imaging, as well as the improved anti-tumor efficacy of monoclonal antibodies (trastuzumab in this case) and doxorubicin (DOX)-containing liposomes. Interestingly, the improvement is most significant for the delivering of compounds that have active or passive tumor targeting ability, such as antibodies or NPs that have enhanced permeability and retention (EPR) effect. However, for non-targeting small molecules, the effect is not significant. In vitro and in vivo studies suggest that both peptosomes and the coadministered compounds might be internalized into cells through a NRP1 mediated co-endocytosis (CoE) pathway. The improved delivery of coadministered NPs and antibodies to tumors suggests that the coadministration with APPA self-assembled peptosomes could be a valuable approach for advancing αvβ3 and NRP1 positive tumors diagnosis and therapy.
AuthorsZhichu Xiang, Gexuan Jiang, Xiaoliang Yang, Di Fan, Xiaohui Nan, Dan Li, Zhiyuan Hu, Qiaojun Fang
JournalBiomolecules (Biomolecules) Vol. 9 Issue 5 (05 05 2019) ISSN: 2218-273X [Electronic] Switzerland
PMID31060320 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptides
  • liposomal doxorubicin
  • Neuropilin-1
  • Polyethylene Glycols
  • Doxorubicin
  • Trastuzumab
Topics
  • Animals
  • Cell Line, Tumor
  • Doxorubicin (administration & dosage, analogs & derivatives, pharmacology, therapeutic use)
  • Drug Delivery Systems
  • Endocytosis (drug effects)
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Magnetosomes
  • Mice, Inbred BALB C
  • Nanoparticles (administration & dosage)
  • Neoplasms (drug therapy, pathology)
  • Neuropilin-1 (metabolism)
  • Peptides (administration & dosage)
  • Polyethylene Glycols (administration & dosage, pharmacology, therapeutic use)
  • Trastuzumab (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: